Three corporations form a cartel to control the production of insulin: Eli Lilly, Novo Nordisk, and Sanofi.

These corporations have been hiking prices in lockstep with each other, for years on end. Now the price of lifesaving insulin is criminally high.

The Federal Trade Commission has the authority to investigate the insulin cartel’s anticompetitive behavior. That investigation should take place. Now.

Investigating collusion in the insulin industry would be the first step in holding these corrupt Pharma corporations accountable.